But like millions of people who struggled with obesity, Kathryn started taking a GLP-1 drug about two years ago and was able to break that cycle
[DOI] [PubMed] [Google Scholar] 111.Lincoff A.M., Brown-Frandsen K., Colhoun H.M., Deanfield J., Emerson S.S., Esbjerg S., Hardt-Lindberg S., Hovingh G.K., Kahn S.E., Kushner R.F., et al
People often report feeling fuller sooner and experiencing fewer cravings within the first few weeks of treatment
These actions contribute to reduced systemic and local inflammation, improved endothelial function, and decreased oxidative stress [10]
Work with knowledgeable healthcare professionals
This basic understanding could provide us with a path to better treating cardiovascular-kidney-metabolic syndrome in patients living with kidney disease. UC Davis coauthors of the study include Brian J